Global Vaccin Antirabic Market Size, Share and Trends Analysis Report, By Type (Gopher Kidney Cell Vaccine, Freeze-Dried Vero Cell Vaccine, Common Vero Cell Vaccine, Human Diploid Vaccine), By Application (Pre-exposure Prophylaxis, After Exposure Prophylaxis, Additional Doses), Forecast (2022-2028)

The global vaccin antirabic market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Developing an effective and high-quality vaccine is an important factor in preventing rabies. This article presents the results of a study aimed at selecting appropriate parameters for the implantation of the VN-21 finite cell line and the CVS-11 type of rabies virus. Limitations such as inoculated cell concentration, total viral load, time and planting methods, and inactivate and adjuvant selection were selected. The increasing prevalence of rabies is anticipated to drive the global vaccin antirabic market.

 

Pre-exposure Prophylaxis is anantirabic vaccine designed to protect a person from getting rabies before being exposed to a rabies-infected animal. The people who benefit most from this pre-exposure prophylaxis are those who are at high risk for contact with saliva, body fluids, or tissue from animals with rabies, which increases the risk of developing rabies. After receiving a vaccine before exposure, if a person develops rabies, you need to get only 2 doses of modern anti-rabies drug/cell culture. And rabies immunoglobulin will not be needed as part of post-exposure prophylaxis, which is expensive and sometimes difficult to procure.

 

Additionally, pre-exposure prophylaxis in the administration of rabies vaccines encourages the immune system to produce antibodies against the rabies virus. The immune system develops within seven to 14 days after vaccination and can eradicate the rabies virus when exposed. Vaccination before exposure leads to the formation of memory cells that remain in the body throughout life. When they are exposed again, it can stimulate the production of weakened antibodies in a short time. However, two doses of re-exposure vaccine are recommended to increase the good number of antibodies as soon as possible to reduce any amount of rabies virus that may enter the body when it is re-exposed.

 

Antirabic vaccine is considered safe and effective based on many clinical studies and previous experience information from millions of people. In some cases, minor local reactions, such as temporary pain, itching, swelling, and redness may occur at the injection site. It is reaction usually subsides within a few days.However, some people may experience side effects such as headaches, body aches, discomfort, nausea, and dizziness. Rarely there is high fever, stomach symptoms, swollen glands, many red spots, rash, joint pain. Occasionally, there may be a severe reaction called anaphylaxis that may cause shortness of breath and low blood pressure. It is important to consult your treating doctor as soon as possible in case of any side effects. All side effects can be successfully controlled if treated promptly.

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-Guangzhou Nuocheng Biological, Merck & Co. Inc., Ningbo Rongan Biological Pharmaceutical, Sanofi, and Zhongke Biological, among others.

 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Vaccin Antirabic Market Report by Segment

By Type

• Gopher Kidney Cell Vaccine
• Freeze-Dried Vero Cell Vaccine
• Common Vero Cell Vaccine
• Human Diploid Vaccine

By Application

• Pre-exposure Prophylaxis
• After-exposure Prophylaxis
• Additional Doses

 

Global Vaccin Antirabic Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa